Rural Health
Resources by Type: Document
Key Findings from the Evaluation of the Tribal HPOG 2.0 Program, 2015-2020
Features an evaluation of the Tribal Health Profession Opportunity Grant 2.0 Program. Highlights funded programs, their service areas, and participant data pertaining to healthcare education, training, and employment.
Date: 09/2021
Sponsoring organizations: Administration for Children and Families, Office of Planning, Research, and Evaluation
view details
Features an evaluation of the Tribal Health Profession Opportunity Grant 2.0 Program. Highlights funded programs, their service areas, and participant data pertaining to healthcare education, training, and employment.
Date: 09/2021
Sponsoring organizations: Administration for Children and Families, Office of Planning, Research, and Evaluation
view details
Wisconsin PDO Grant Final Report: Prescription Drug/Opioid Overdose-Related Deaths Prevention Project
Reports on the outcomes of the Wisconsin Prescription Drug/Opioid Overdose-Related Death Prevention (PDO) project grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA). Includes statistics on the rural and urban counties selected to receive the project services such as estimated population with opioid use disorder (OUD), poverty, and more. Describes project activities and strategies focused on reducing the number of opioid-related deaths and adverse events, developing and implementing secondary prevention programs, and providing overdose survivors and their families with services and support within 72 hours of overdose.
Author(s): Kylie Lafayette, Elizabeth Feder, Tom Bently
Date: 09/2021
Sponsoring organization: University of Wisconsin Population Health Institute
view details
Reports on the outcomes of the Wisconsin Prescription Drug/Opioid Overdose-Related Death Prevention (PDO) project grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA). Includes statistics on the rural and urban counties selected to receive the project services such as estimated population with opioid use disorder (OUD), poverty, and more. Describes project activities and strategies focused on reducing the number of opioid-related deaths and adverse events, developing and implementing secondary prevention programs, and providing overdose survivors and their families with services and support within 72 hours of overdose.
Author(s): Kylie Lafayette, Elizabeth Feder, Tom Bently
Date: 09/2021
Sponsoring organization: University of Wisconsin Population Health Institute
view details
Wisconsin Final Report: Strategic Prevention Framework for Prescription Drugs (SPF Rx)
Reports the outcomes of the Strategic Prevention Framework for Prescription Drugs (SPF Rx) project grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) for the state of Wisconsin. Describes activities and strategies focused in rural Dodge and Sauk counties to reduce prescription opioid drug misuse, build local coalitions to address prevention needs, and establish a statewide surveillance system to monitor prescription opioid misuse.
Author(s): Elizabeth Feder, Kylie Lafayette
Date: 09/2021
Sponsoring organization: University of Wisconsin Population Health Institute
view details
Reports the outcomes of the Strategic Prevention Framework for Prescription Drugs (SPF Rx) project grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) for the state of Wisconsin. Describes activities and strategies focused in rural Dodge and Sauk counties to reduce prescription opioid drug misuse, build local coalitions to address prevention needs, and establish a statewide surveillance system to monitor prescription opioid misuse.
Author(s): Elizabeth Feder, Kylie Lafayette
Date: 09/2021
Sponsoring organization: University of Wisconsin Population Health Institute
view details
Addressing Health-Related Social Needs to Improve Rural Health: Ideas to Action
Identifies strategies for building community and regional systems of care to better address the social needs of patients and inform the design of community-level rural health transformation initiatives, pilots, or demonstrations in rural Maine. Examines existing literature and evidence from similar initiatives in Vermont, Idaho, and Oregon, and highlights key observations. Describes key components of a demonstration designed to build, implement, and test strategies for aligning health, social service, and other systems in order to advance whole-person care.
Author(s): Andrew F. Coburn, Deborah A. Deatrick
Date: 09/2021
Sponsoring organizations: Maine Rural Health Action Network, New England Rural Health Association
view details
Identifies strategies for building community and regional systems of care to better address the social needs of patients and inform the design of community-level rural health transformation initiatives, pilots, or demonstrations in rural Maine. Examines existing literature and evidence from similar initiatives in Vermont, Idaho, and Oregon, and highlights key observations. Describes key components of a demonstration designed to build, implement, and test strategies for aligning health, social service, and other systems in order to advance whole-person care.
Author(s): Andrew F. Coburn, Deborah A. Deatrick
Date: 09/2021
Sponsoring organizations: Maine Rural Health Action Network, New England Rural Health Association
view details
Prenatal Alcohol and Other Drug Exposures in Child Welfare Study: Final Report
Reports the findings of a study examining 22 child welfare agencies in 5 states to determine how agencies obtain information about prenatal substance exposure (PSE) when a child is involved with the child welfare system and how agencies use PSE information to provide services and support for affected children and their families. Exhibit 4 describes the characteristics and key features of the states and child welfare agencies involved in the study, including a breakdown of rural and urban counties.
Author(s): E. Ingoldsby, T. Richards, K. Usher, et al.
Date: 09/2021
Sponsoring organization: Administration for Children and Families
view details
Reports the findings of a study examining 22 child welfare agencies in 5 states to determine how agencies obtain information about prenatal substance exposure (PSE) when a child is involved with the child welfare system and how agencies use PSE information to provide services and support for affected children and their families. Exhibit 4 describes the characteristics and key features of the states and child welfare agencies involved in the study, including a breakdown of rural and urban counties.
Author(s): E. Ingoldsby, T. Richards, K. Usher, et al.
Date: 09/2021
Sponsoring organization: Administration for Children and Families
view details
Tribal Child Welfare Systems' Experiences with Prenatal Exposure to Alcohol and Other Drugs: A Case Study
Shares the results of a federally-funded case study examining existing approaches and practices to identify and care for Native American children with prenatal substance exposure (PSE) and their families from the Red Lake Nation in Minnesota. Offers discussion and implications for tribal child welfare programs and federal agencies working with tribes to address child welfare issues.
Author(s): Priscilla Day, Erin Geary, Erin Ingoldsby, Pirkko Ahonen
Date: 09/2021
Sponsoring organization: Administration for Children and Families
view details
Shares the results of a federally-funded case study examining existing approaches and practices to identify and care for Native American children with prenatal substance exposure (PSE) and their families from the Red Lake Nation in Minnesota. Offers discussion and implications for tribal child welfare programs and federal agencies working with tribes to address child welfare issues.
Author(s): Priscilla Day, Erin Geary, Erin Ingoldsby, Pirkko Ahonen
Date: 09/2021
Sponsoring organization: Administration for Children and Families
view details
Inequities in the Geographic Accessibility of COVID-19 Biomedical Therapeutic Trials in the United States
Research report examining geographic proximity to COVID-19 biomedical therapeutic trial sites, breaking down U.S. clinical trial data by rural/urban location, age, and race/ethnicity. Charts depict drive times to trial sites for each demographic group, comparing rural and urban populations.
Author(s): Rohan Khazanchi, Samuel D. Powers, Elizabeth T. Rogawski McQuade, Kathleen A. McManus
Citation: Journal of General Internal Medicine
Date: 09/2021
view details
Research report examining geographic proximity to COVID-19 biomedical therapeutic trial sites, breaking down U.S. clinical trial data by rural/urban location, age, and race/ethnicity. Charts depict drive times to trial sites for each demographic group, comparing rural and urban populations.
Author(s): Rohan Khazanchi, Samuel D. Powers, Elizabeth T. Rogawski McQuade, Kathleen A. McManus
Citation: Journal of General Internal Medicine
Date: 09/2021
view details
An Evaluation of Telehealth Use by Medicare Beneficiaries in 2020
Research brief examining telehealth use for outpatient evaluation and management from January 2019 to December 2020 based on a 20% sample of fee-for-service Medicare beneficiaries. Charts monthly trends for in-person and telehealth visits and compares rural and urban telehealth use, offering policy implications related to rural access to services.
Author(s): Chad Ellimoottil, Ziwei Zhu, Rod Dunn, et al.
Date: 09/2021
Sponsoring organization: University of Michigan Institute for Healthcare Policy and Innovation
view details
Research brief examining telehealth use for outpatient evaluation and management from January 2019 to December 2020 based on a 20% sample of fee-for-service Medicare beneficiaries. Charts monthly trends for in-person and telehealth visits and compares rural and urban telehealth use, offering policy implications related to rural access to services.
Author(s): Chad Ellimoottil, Ziwei Zhu, Rod Dunn, et al.
Date: 09/2021
Sponsoring organization: University of Michigan Institute for Healthcare Policy and Innovation
view details
Health Panel Comment Letter – Rural Emergency Hospitals (REH)
Offers comments in response to the Centers for Medicare and Medicaid Services (CMS) Request for Information on Rural Emergency Hospitals (REH). Addresses the type and scope of services REHs could offer, conditions of participation, health equity, collaboration and care coordination, quality measurement, payment, and enrollment.
Date: 09/2021
Sponsoring organization: Rural Policy Research Institute Rural Health Panel
view details
Offers comments in response to the Centers for Medicare and Medicaid Services (CMS) Request for Information on Rural Emergency Hospitals (REH). Addresses the type and scope of services REHs could offer, conditions of participation, health equity, collaboration and care coordination, quality measurement, payment, and enrollment.
Date: 09/2021
Sponsoring organization: Rural Policy Research Institute Rural Health Panel
view details
Outcome Comparison of High-Risk Native American Patients Who Did or Did Not Receive Monoclonal Antibody Treatment for COVID-19
Results of a monoclonal antibody (mAb) treatment program for high-risk Native American patients at a rural acute care facility on the Fort Apache Indian Reservation in eastern Arizona. Features demographics and statistics comparing 30-day outcomes among patients who did or did not receive mAb treatment between December 2020 and February 2021.
Author(s): Ryan M. Close, T. Shaifer Jones, Christopher Jentoft, James B. McAuley
Citation: JAMA Network Open, 4(9)
Date: 09/2021
view details
Results of a monoclonal antibody (mAb) treatment program for high-risk Native American patients at a rural acute care facility on the Fort Apache Indian Reservation in eastern Arizona. Features demographics and statistics comparing 30-day outcomes among patients who did or did not receive mAb treatment between December 2020 and February 2021.
Author(s): Ryan M. Close, T. Shaifer Jones, Christopher Jentoft, James B. McAuley
Citation: JAMA Network Open, 4(9)
Date: 09/2021
view details